MabionCD20® Compared to MabThera® and Rituxan® in Patients With Rheumatoid Arthritis

Clinical trial NCT04680962 · WITHDRAWN

Trial details

NCT number: NCT04680962
Sponsor: Mabion SA
Status: WITHDRAWN
Phase: Phase 3
Study type: INTERVENTIONAL

Rheumatoid Arthritis

Start date: 2023-08-03
Primary completion: 2023-08-03
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.